Featured News - Current News - Archived News - News Categories

Dr. Artem Evdokimov Joins HarkerBIO as CSO

Introducing the New CSO of HarkerBIO

Mon, Jul 20th 2015 03:00 pm

Dr. Artem Evdokimov Joins HarkerBIO in Buffalo, NY as CSO

Artem received a dual PhD in Chemistry and Structural Biology from the Weizmann Institute of Science in Israel. He then spent two years at the National Institutes of Health (NCI-Frederick in the lab of Dr. David Waugh) where he studied Yersinia pestis, the bacterial pathogen that causes the notorious Bubonic Plague. 

Dr. Evdokimov has worked for Procter & Gamble Pharmaceuticals and Pfizer, where he used structural biology as a tool to assist in the development of potential new treatments for infectious diseases, CNS ailments, cardiovascular conditions and cancer. Most recently he has led a Structure and Design team at Monsanto, where his work enabled the development of novel traits to protect plants against insect predation, to elicit herbicide tolerance, or to enhance yield. To-date Artem worked on many difficult proteins, resulting in 15+ issued patent applications, approximately fifty peer-reviewed publications, and over a hundred PDB crystal structure entries (thousands of structures solved, but most of them remain proprietary for now).

Artem's personal web site (not entirely up to date) is www.xtals.org - there you can find a relatively complete list of his publications and Protein Data Bank entries as well as other materials of interest.